Annotation Detail

Information
Associated Genes
TP53
Associated Variants
TP53 MUTATION
TP53 MUTATION
Associated Disease
ovarian carcinoma
Source Database
DisGeNET
Description
Although the effect of new drugs such as poly(ADP-ribose) polymerase inhibitors are being investigated in ovarian cancer, there is still a need to develop targeted therapies-especially to tackle mutations in PI3 K pathway, RAS pathway and TP53.
Pubmed
25473022
Section of the abstract supporting the evidence
AREAS FOR TIMELY RESEARCH
Number of the section of the abstract supporting the evidence
6
Number of the sentence supporting the evidence
14
Original source reporting the Gene Disease association
BeFree,GAD
DisGENET score for the Gene Disease association
0.0847340639572041
Drugs